Trial intelligence / Profile preview

Influence of CYP450 Genotypes on Naproxen and Naproxen-Esomeprazole PK

NCT03092193Phase 4Completed

Sponsor
Universidade de São Paulo
Start
Mar 2017
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of naproxen, esomeprazole in pain, inflammation, sponsored by Universidade de São Paulo. Started Mar 2017; status: completed.

02

Drugs

naproxenesomeprazole
03

Conditions

paininflammation

Beyond the preview

Go deeper on NCT03092193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03092193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call